Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR

Overview Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR

Metformin/Voglibose/Pioglitazone extended-release tablets (0.3mg/1mg/500mg) are a triple-combination therapy for type 2 diabetes. This medication manages blood sugar by slowing glucose absorption, boosting insulin secretion, reducing liver glucose production, and enhancing insulin sensitivity. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood glucose monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source (e.g., sugary food or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include rash, altered taste, nausea, gas, diarrhea, abdominal pain, appetite changes, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vogli-Rapid M 0.3mg/1mg/500mg Extended-Release tablets with food.

Common Side effects of Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR:

• Skin rash
• Taste change
• Nausea
• Flatulence
• Diarrhea
• Stomach pain
• Loss of appetite
• Hypoglycemia (low blood glucose level)

How to use Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogli-Rapid M 0.3mg/1mg/500mg Extended-Release tablets should be taken with a meal.

How Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR works:

Vogli-Rapid M SR tablets (0.3mg/1mg/500mg) combine voglibose, repaglinide, and metformin to manage blood sugar. Voglibose inhibits intestinal enzymes responsible for carbohydrate digestion, slowing glucose absorption. Repaglinide stimulates insulin release from the pancreas post-meal. This dual action prevents significant postprandial hyperglycemia. Metformin concurrently reduces hepatic glucose production, diminishes intestinal glucose uptake, and enhances insulin sensitivity.

What if you forget to take Vogli-Rapid M 0.3mg/1mg/500mg Tablet SR :

NA